Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029921 | 12602992 | 1 | I | 20140307 | 20151011 | 20160728 | 20160728 | EXP | DE-GILEAD-2015-0176935 | GILEAD | 55.00 | YR | A | F | Y | 74.00000 | KG | 20160728 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029921 | 12602992 | 1 | PS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | 400 MG, QD | 21200 | MG | U | 204671 | 400 | MG | TABLET | QD | |||
| 126029921 | 12602992 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 200 MG, BID | 67600 | MG | U | 0 | 200 | MG | BID | ||||
| 126029921 | 12602992 | 3 | C | FUROSEMID /00032601/ | FUROSEMIDE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 126029921 | 12602992 | 4 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 126029921 | 12602992 | 5 | C | HEPA-MERZ /06109201/ | 2 | 12 G, QD | 792.80994 | G | 0 | 12 | G | QD | |||||||
| 126029921 | 12602992 | 6 | C | HEPA-MERZ /06109201/ | 2 | 6 G, QD | 792.80994 | G | 0 | 6 | G | QD | |||||||
| 126029921 | 12602992 | 7 | C | SPIRONOLACTON | SPIRONOLACTONE | 1 | 200 MG, QD | 0 | 200 | MG | QD | ||||||||
| 126029921 | 12602992 | 8 | C | CARVEDILOL. | CARVEDILOL | 1 | 12.5 MG, QD | 0 | 12.5 | MG | QD | ||||||||
| 126029921 | 12602992 | 9 | C | LACTULOSE. | LACTULOSE | 1 | 15 ML, QD | 0 | 15 | ML | QD | ||||||||
| 126029921 | 12602992 | 10 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | 80 MG, QD | 0 | 80 | MG | QD | ||||||||
| 126029921 | 12602992 | 11 | C | FERROSANOL | FERROUS GLUCONATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126029921 | 12602992 | 1 | Chronic hepatitis C |
| 126029921 | 12602992 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126029921 | 12602992 | OT |
| 126029921 | 12602992 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126029921 | 12602992 | Abdominal pain lower | |
| 126029921 | 12602992 | Dyspnoea | |
| 126029921 | 12602992 | Haemoglobin decreased | |
| 126029921 | 12602992 | Headache | |
| 126029921 | 12602992 | Pruritus | |
| 126029921 | 12602992 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126029921 | 12602992 | 1 | 20140212 | 20140729 | 0 | |
| 126029921 | 12602992 | 2 | 20140210 | 20140729 | 0 | |
| 126029921 | 12602992 | 3 | 20151030 | 0 | ||
| 126029921 | 12602992 | 4 | 20140825 | 0 | ||
| 126029921 | 12602992 | 5 | 20140725 | 0 | ||
| 126029921 | 12602992 | 6 | 20140725 | 20150205 | 0 | |
| 126029921 | 12602992 | 9 | 20150205 | 0 | ||
| 126029921 | 12602992 | 11 | 20151030 | 0 |